QualifyHQ Logo

Enso

ENYO Pharma is a clinical-stage biopharmaceutical company developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function.The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome.

Gegrënnt

2014

Ëmsaz

$2.5M - $5.0M

Finanzéierung

$108.8M

Ähnlech Firmen kucken

Qualify this Company in

minutes

Wärend aner Tools Zäit verschwenden, hëllefe mir Iech, besser passend Firmen a Minutten ze qualifizéieren - sou bleift Är Pipeline gesond, Äert Team produktiv an Är Deals beweege sech méi séier.

Start free trial

Start 7-Day Free Trial